Protocols

Based on available clinical trial evidence, acarbose dosing protocols typically follow these patterns:

Initial Dosing:

Starting dose is commonly 25 mg three times daily with meals
Some protocols begin with 25 mg once or twice daily to assess tolerance

Dose Escalation:

Gradual increases every 4-8 weeks based on patient response and tolerability
Typical progression: 25 mg → 50 mg → 100 mg three times daily with meals

Maximum Dosing:

Standard formulations: Up to 100 mg three times daily with meals
For patients >60 kg: Maximum 100 mg three times daily
For patients <60 kg: Maximum 50 mg three times daily

Administration Guidelines:

Must be taken with the first bite of each main meal
Tablets should be chewed with food or swallowed whole with liquid during meals
Orally disintegrating tablet (ODT) formulations are bioequivalent to standard tablets

Combination Therapy:
Clinical trials have evaluated acarbose in combination with:

Metformin (particularly in newly diagnosed type 2 diabetes patients)
Sitagliptin (DPP-4 inhibitor)
Other α-glucosidase inhibitors

The evidence base for specific dosing protocols is limited in the provided literature, with most studies focusing on drug development or combination therapies rather than detailed dosing guidelines.

Disclaimer: This information is for educational purposes only and does not constitute personalized medical advice. Dosing should always be individualized based on patient factors, comorbidities, and clinical response under physician supervision.

Acarbose

Member access required